CoachMS, an innovative closed-loop, interdisciplinary platform to monitor and proactively treat MS symptoms: A pilot study.

ABSTRACT:

Background

There are numerous challenges to treating co-occurring symptoms in multiple sclerosis (MS).

Objective

To pilot the feasibility of a novel symptom management platform, CoachMS, to monitor MS symptoms (bladder function, ambulation, and mood: BAM) and respond to changes in real-time.

Methods

In this 12-week randomized controlled pilot trial, participants' symptoms were monitored using weekly questionnaires and remote ambulatory monitoring (Fitbit Flex2®). Behavioral change principles used included shared goal setting at 2 weeks. Between weeks 2-12, the CoachMS group received targeted contact and interventions if symptoms worsened; the control group were treated through usual clinic practice. Our outcomes were feasibility (retention, adherence and acceptability

SUBMITTER: Block VJ 

PROVIDER: S-EPMC7970691 | biostudies-literature | 2021 Jan-Mar

REPOSITORIES: biostudies-literature